ArticleIndian journal of orthopaedics2025
Evolution of Metals and Alloys in Orthopedics with Their Relevance in Osteoporosis.
Article in Indian journal of orthopaedics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The evolution of metals and alloys in orthopedics has significantly improved the management of bone-related disorders, particularly osteoporosis, where decreased bone density and fragility complicate implant stability and healing. Traditional materials such as stainless steel and cobalt-chromium alloys provided strength and wear resistance but were associated with challenges like stress shielding and implant loosening. Materials and Methods: To address these limitations, titanium alloys emerged as a superior alternative due to their biocompatibility, lightweight nature, and bone-like elasticity, making them suitable for osteoporotic patients. Recent advancements have led to the development of magnesium-based biodegradable implants and nitinol (shape-memory alloy), which enable minimally invasive procedures and provide dynamic support. Additionally, porous and bioactive coatings, such as hydroxyapatite (HA), have been introduced to enhance osseointegration and implant fixation in compromised bone. Results: The integration of pharmacological strategies, such as bisphosphonates and sclerostin antibodies, with advanced implant surfaces has further enhanced bone regeneration. Emerging innovations, including 3D-printed personalized implants and smart alloys capable of adapting to physiological changes, show promise for improved long-term stability and faster recovery in osteoporotic patients. Conclusion: The continuous development of orthopedic materials has paved the way for more effective treatments for osteoporosis, addressing key challenges such as implant stability, stress shielding, and bone regeneration. Innovations in bioactive coatings, biodegradable metals, and personalized implants represent the future of orthopedic care, offering improved outcomes for patients with compromised bone health. However, continuous research is essential to optimize these technologies for broader clinical applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.